Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data?

TheFly reported connected June 15 that Citizens reiterated its affirmative stance connected MIRM, expanding its terms nonsubjective to $146 from $140. The steadfast pointed to the increasing imaginable of Mirum's precocious acquired zilurgisertib program, citing updated findings that demonstrated encouraging objective enactment successful fibrodysplasia ossificans progressiva (FOP). Although the Phase 2b survey did not execute its superior goal, the further information strengthened the presumption that the therapy could inactive beforehand toward regulatory approval. Citizens besides highlighted the asset's commercialized prospects and noted that its integration with Mirum's existing operations could enactment a comparatively accelerated publication to the company's business.

Separately, connected June 11, Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) announced that its Compensation Committee approved inducement awards connected June 10, 2026, for 8 recently hired employees nether the company's 2020 Inducement Plan. The grants included non-qualified banal options covering 10,100 shares of communal banal and 13,350 restricted banal units (RSUs), issued successful accordance with Nasdaq Listing Rule 5635(c)(4) arsenic portion of the employees' hiring incentives. The banal options were granted astatine an workout terms of $94.00 per share, matching the company's closing banal terms connected the assistance date, and volition vest implicit 4 years. The RSUs volition vest implicit 3 years, with some awards remaining taxable to continued employment and the presumption of the applicable grant agreements.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) is simply a commercial-stage biopharmaceutical institution processing therapies for uncommon diseases, with a absorption connected liver and metabolic disorders caused by bile acerb dysfunction.

While we admit the imaginable of MIRM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.